Results 251 to 260 of about 793,602 (347)
Objective We conducted formative research aimed at identifying solutions that address inequitable health outcomes in lupus due to adverse social determinants of health. Methods We conducted a search for keywords which provided insights into potential solutions and initiatives underway. An advisory panel of lupus experts iteratively reviewed the list of
Joy Buie+11 more
wiley +1 more source
Internal mammary node irradiation in early breast cancer - target coverage and implications on dose to organs at risk. [PDF]
Berg L+5 more
europepmc +1 more source
Recently, there has been growing discussion about how to best assess pain in clinical trials in rheumatic diseases. Reliable measurement of pain outcomes is essential for accurately determining the effectiveness of treatments. While pain intensity is the most common measure of change in pain trials, other pain‐related measures, such as pain ...
Yen T. Chen+4 more
wiley +1 more source
PodGPT: an audio-augmented large language model for research and education. [PDF]
Jia S+10 more
europepmc +1 more source
Knee crepitus and osteoarthritis features in young adults following traumatic knee injury
Objective This study explored the association between knee crepitus and the presence, and worsening, of structural osteoarthritis features and self‐reported outcomes in young adults following traumatic knee injury. Methods One‐year following anterior cruciate ligament reconstruction (ACLR), 112 participants (41 female participants; median age 28 years)
Jamon L Couch+8 more
wiley +1 more source
Correction: Narayanaswamy et al. Synthesis of Graphene Oxide-Fe<sub>3</sub>O<sub>4</sub> Based Nanocomposites Using the Mechanochemical Method and In Vitro Magnetic Hyperthermia. <i>Int. J. Mol. Sci.</i> 2019, <i>20</i>, 3368. [PDF]
Narayanaswamy V+8 more
europepmc +1 more source
Background/Aims Asymptomatic hyperuricemia is a precursor of gout and is also associated with cardiovascular disease and chronic kidney disease. The aim of this study was to understand perceptions about asymptomatic hyperuricemia and views about urate‐lowering therapy in people with asymptomatic hyperuricemia.
Nicola Dalbeth+19 more
wiley +1 more source